Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer.

[1]  B. Trock,et al.  A critical analysis of the interpretation of biochemical failure in surgically treated patients using the American Society for Therapeutic Radiation and Oncology criteria. , 2002, The Journal of urology.

[2]  Juni Palmgren,et al.  A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. , 2002, The New England journal of medicine.

[3]  L. Holmberg,et al.  Quality of life after radical prostatectomy or watchful waiting. , 2002, The New England journal of medicine.

[4]  C. Reddy,et al.  Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  George Starkschall,et al.  Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. , 2002, International journal of radiation oncology, biology, physics.

[6]  John E Tomaszewski,et al.  Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era , 2002, Cancer.

[7]  A. Hanlon,et al.  Posttreatment prostate-specific antigen nadir highly predictive of distant failure and death from prostate cancer. , 2002, International journal of radiation oncology, biology, physics.

[8]  C. Reddy,et al.  Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era. , 2002, International journal of radiation oncology, biology, physics.

[9]  D. Brachman,et al.  Failure free survival following brachytherapy alone for prostate cancer: comparison with external beam radiotherapy. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  M. Kattan,et al.  The definition of biochemical failure in patients treated with definitive radiotherapy. , 2000, International journal of radiation oncology, biology, physics.

[11]  D. Brachman,et al.  Failure-free survival following brachytherapy alone or external beam irradiation alone for T1-2 prostate tumors in 2222 patients: results from a single practice. , 2000, International journal of radiation oncology, biology, physics.

[12]  L. Potters.  Permanent prostate brachytherapy: lessons learned, lessons to learn. , 2000, Oncology.

[13]  J. Blasko,et al.  Permanent source brachytherapy for prostate cancer. American College of Radiology. ACR Appropriateness Criteria. , 2000, Radiology.

[14]  Ravinder Nath,et al.  American Brachytherapy Society recommendations for clinical implementation of NIST-1999 standards for 103palladium brachytherapy , 2000 .

[15]  L. Potters,et al.  The role of external beam irradiation in patients undergoing prostate brachytherapy. , 2000, Urologic oncology.

[16]  C. Reddy,et al.  Higher than standard radiation doses (> or =72 Gy) with or without androgen deprivation in the treatment of localized prostate cancer. , 2000, International journal of radiation oncology, biology, physics.

[17]  E. Klein,et al.  Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results. , 1999, Urology.

[18]  P. Grimm,et al.  American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. , 1999, International journal of radiation oncology, biology, physics.

[19]  A W Partin,et al.  Natural history of progression after PSA elevation following radical prostatectomy. , 1999, JAMA.

[20]  W. Catalona,et al.  Retrospective comparison of radical retropubic prostatectomy and 125iodine brachytherapy for localized prostate cancer. , 1999, The Journal of urology.

[21]  A. Renshaw,et al.  Biochemical Outcome after radical prostatectomy, external beam Radiation Therapy, or interstitial Radiation therapy for clinically localized prostate cancer , 1998 .

[22]  William R. Fair,et al.  DOSE ESCALATION WITH THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY AFFECTS THE OUTCOME IN PROSTATE CANCER , 1998 .

[23]  P. Walsh,et al.  Comparison of radical prostatectomy and iodine 125 interstitial radiotherapy for the treatment of clinically localized prostate cancer: a 7-year biochemical (PSA) progression analysis. , 1998, Urology.

[24]  D. Paulson.  Radical perineal prostatectomy. , 1998, Current opinion in urology.

[25]  J. Blasko,et al.  Interstitial iodine‐125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma , 1997, Cancer.

[26]  A. D'Amico,et al.  Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of > 4-20 ng/ml. , 1997, International journal of radiation oncology, biology, physics.

[27]  James D. Cox,et al.  Consensus statement: Guidelines for PSA following radiation therapy , 1997 .

[28]  G. Hanks.  More on the Uro-Oncology Research Group report of radical surgery vs. radiotherapy for adenocarcinoma of the prostate. , 1988, International journal of radiation oncology, biology, physics.

[29]  T. Stamey,et al.  Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate , 1987 .

[30]  W Hinshaw,et al.  Radical surgery versus radiotherapy for adenocarcinoma of the prostate. , 1982, The Journal of urology.

[31]  C. Iselin,et al.  Radical perineal prostatectomy: oncological outcome during a 20-year period. , 1999, The Journal of urology.

[32]  P. Walsh,et al.  Radical prostatectomy for the treatment of localized prostatic carcinoma. , 1980, The Urologic clinics of North America.